Fresh analysis suggests that patients who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who end conventional lifestyle regimens.
Published data in a leading health publication demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"Users buying such treatments must be cognizant of the potential of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight within about 18 months.
Comparing Therapies
The study, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with conventional dieting.
Scientists note that people who shed pounds through lifestyle changes alone typically have a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Experts suggest the mode of action of the jabs accounts for the amplified weight return.
The injections copy a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 levels far above than normal could lead to the system to produce less of its endogenous GLP-1, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication results in appetite is uncontrolled, making binge eating much more probable."
A Lifelong Disease?
Health authorities advise the injections for people with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians say that, given the high risk of weight regain, the treatment is often life-long.
This view is echoed by drug manufacturers, who state that the findings "emphasize the chronic character of excess weight," similar to managing diseases like diabetes.
Patient Accounts
Users who have discontinued the jabs describe a sudden resurgence of cravings.
"It was like something that goes on and I was suddenly extremely hungry," recalled a patient.
This difficulty is compounded if individuals have not adopted sustainable dietary or behavioural changes during treatment.
Widespread Interest
Survey data indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is higher among women compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, experts caution that while GLP-1 drugs are potent tools for weight loss, they are not a permanent cure and maintained weight loss hinges on integrated lifestyle changes.
